Warmuth Markus

Monte Rosa Therapeutics, Inc. · President & CEO

Warmuth Markus is listed in public filings as director, officer: President & CEO. This Warmuth Markus insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Monte Rosa Therapeutics, Inc. (GLUE). Investors use Warmuth Markus's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Monte Rosa Therapeutics, Inc.GLUE$12M595k sharesSellJun 1, 2026$97.0K5k shares$19.41--
Monte Rosa Therapeutics, Inc.GLUE$12M594.5k sharesSellJun 1, 2026$9.2K468 shares$19.73--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Monte Rosa Therapeutics, Inc.GLUE$11M600k sharesSellMay 1, 2026$103.4K5.5k shares$18.92--
Monte Rosa Therapeutics, Inc.GLUE$11M605.5k sharesSellApr 14, 2026$141.1K8k shares$17.64--
Monte Rosa Therapeutics, Inc.GLUE$11M613.5k sharesSellMar 2, 2026$98.0K5.5k shares$17.92--
Monte Rosa Therapeutics, Inc.GLUE$14M620.7k sharesSellJan 7, 2026$86.2K3.7k shares$23.24--
Monte Rosa Therapeutics, Inc.GLUE$15M619.2k sharesSellJan 7, 2026$34.6K1.5k shares$23.88--
Monte Rosa Therapeutics, Inc.GLUE$15M618.9k sharesSellJan 7, 2026$7.6K309 shares$24.57--
Monte Rosa Therapeutics, Inc.GLUE$9.5M624.4k sharesSellJan 5, 2026$153.7K10.1k shares$15.17--
Monte Rosa Therapeutics, Inc.GLUE$6.2M406k sharesGrant / ExerciseJan 2, 2026$6.2M406k shares$15.31--
Monte Rosa Therapeutics, Inc.GLUE--634.5k sharesGrant / ExerciseJan 2, 2026Disclosure amount unavailable90k shares----
Monte Rosa Therapeutics, Inc.GLUE$4.1M575k sharesGrant / ExerciseJan 2, 2025$4.1M575k shares$7.11--
Monte Rosa Therapeutics, Inc.GLUE--544.5k sharesGrant / ExerciseJan 2, 2025Disclosure amount unavailable128k shares----